
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design,in silico,in vitro, and SAR studies for lead optimization
Maha M. Abdel‐Fattah, Khaled M. Darwish, Raya Soltane, et al.
RSC Advances (2021) Vol. 11, Iss. 56, pp. 35536-35558
Open Access | Times Cited: 56
Maha M. Abdel‐Fattah, Khaled M. Darwish, Raya Soltane, et al.
RSC Advances (2021) Vol. 11, Iss. 56, pp. 35536-35558
Open Access | Times Cited: 56
Showing 1-25 of 56 citing articles:
Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2
Abeer M. El‐Naggar, A.M.A. Hassan, Eslam B. Elkaeed, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105770-105770
Closed Access | Times Cited: 75
Abeer M. El‐Naggar, A.M.A. Hassan, Eslam B. Elkaeed, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105770-105770
Closed Access | Times Cited: 75
In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
Ayman Abo Elmaaty, Khaled M. Darwish, Amani Chrouda, et al.
ACS Omega (2021) Vol. 7, Iss. 1, pp. 875-899
Open Access | Times Cited: 68
Ayman Abo Elmaaty, Khaled M. Darwish, Amani Chrouda, et al.
ACS Omega (2021) Vol. 7, Iss. 1, pp. 875-899
Open Access | Times Cited: 68
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus
Dalia Elebeedy, Ingy Badawy, Ayman Abo Elmaaty, et al.
Computers in Biology and Medicine (2021) Vol. 141, pp. 105149-105149
Closed Access | Times Cited: 56
Dalia Elebeedy, Ingy Badawy, Ayman Abo Elmaaty, et al.
Computers in Biology and Medicine (2021) Vol. 141, pp. 105149-105149
Closed Access | Times Cited: 56
Newly synthesized series of oxoindole–oxadiazole conjugates as potential anti-SARS-CoV-2 agents:in silicoandin vitrostudies
Rana M. El-Masry, Ahmed A. Al‐Karmalawy, Radwan Alnajjar, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 11, pp. 5078-5090
Closed Access | Times Cited: 55
Rana M. El-Masry, Ahmed A. Al‐Karmalawy, Radwan Alnajjar, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 11, pp. 5078-5090
Closed Access | Times Cited: 55
Synthesis, structural characterization, DFT calculations, molecular docking, and molecular dynamics simulations of a novel ferrocene derivative to unravel its potential antitumor activity
Mohamed M. Hammoud, Muhammad Khattab, Marwa Abdel‐Motaal, et al.
Journal of Biomolecular Structure and Dynamics (2022), pp. 1-18
Open Access | Times Cited: 48
Mohamed M. Hammoud, Muhammad Khattab, Marwa Abdel‐Motaal, et al.
Journal of Biomolecular Structure and Dynamics (2022), pp. 1-18
Open Access | Times Cited: 48
Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
Omnia Kutkat, Yassmin Moatasim, Ahmed A. Al‐Karmalawy, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 47
Omnia Kutkat, Yassmin Moatasim, Ahmed A. Al‐Karmalawy, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 47
Potential Valorization of Edible Nuts By-Products: Exploring the Immune-Modulatory and Antioxidants Effects of Selected Nut Shells Extracts in Relation to Their Metabolic Profiles
Mohamed A. Salem, Nora M. Aborehab, Ahmed A. Al‐Karmalawy, et al.
Antioxidants (2022) Vol. 11, Iss. 3, pp. 462-462
Open Access | Times Cited: 43
Mohamed A. Salem, Nora M. Aborehab, Ahmed A. Al‐Karmalawy, et al.
Antioxidants (2022) Vol. 11, Iss. 3, pp. 462-462
Open Access | Times Cited: 43
A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
Nada A. Ashour, Ayman Abo Elmaaty, Amany A. Sarhan, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 685-715
Open Access | Times Cited: 40
Nada A. Ashour, Ayman Abo Elmaaty, Amany A. Sarhan, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 685-715
Open Access | Times Cited: 40
Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
Ayman Abo Elmaaty, Wagdy M. Eldehna, Muhammad Khattab, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12235-12235
Open Access | Times Cited: 40
Ayman Abo Elmaaty, Wagdy M. Eldehna, Muhammad Khattab, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12235-12235
Open Access | Times Cited: 40
In vitroand computational investigations of novel synthetic carboxamide-linked pyridopyrrolopyrimidines with potent activity as SARS-CoV-2-MProinhibitors
Ateyatallah Aljuhani, Hany E. A. Ahmed, Saleh Ihmaid, et al.
RSC Advances (2022) Vol. 12, Iss. 41, pp. 26895-26907
Open Access | Times Cited: 39
Ateyatallah Aljuhani, Hany E. A. Ahmed, Saleh Ihmaid, et al.
RSC Advances (2022) Vol. 12, Iss. 41, pp. 26895-26907
Open Access | Times Cited: 39
Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: In Vitro, in Vivo, molecular docking, molecular dynamics, and SAR studies
Mohamed M. Hammouda, Ayman Abo Elmaaty, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105995-105995
Closed Access | Times Cited: 38
Mohamed M. Hammouda, Ayman Abo Elmaaty, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105995-105995
Closed Access | Times Cited: 38
Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice
Amany A. Alzokaky, Ahmed A. Al‐Karmalawy, Mohamed A. Saleh, et al.
Life Sciences (2023) Vol. 316, pp. 121390-121390
Closed Access | Times Cited: 22
Amany A. Alzokaky, Ahmed A. Al‐Karmalawy, Mohamed A. Saleh, et al.
Life Sciences (2023) Vol. 316, pp. 121390-121390
Closed Access | Times Cited: 22
Ligand-based design and synthesis of N'-Benzylidene-3,4-dimethoxybenzohydrazide derivatives as potential antimicrobial agents; evaluation by in vitro, in vivo, and in silico approaches with SAR studies
Rogy R. Ezz Eldin, Marwa A. Saleh, Mohammad Hayal Alotaibi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1098-1119
Open Access | Times Cited: 35
Rogy R. Ezz Eldin, Marwa A. Saleh, Mohammad Hayal Alotaibi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1098-1119
Open Access | Times Cited: 35
A novel role of Nano selenium and sildenafil on streptozotocin-induced diabetic nephropathy in rats by modulation of inflammatory, oxidative, and apoptotic pathways
Mona F. El-Azab, Ahmed A. Al‐Karmalawy, Samar A. Antar, et al.
Life Sciences (2022) Vol. 303, pp. 120691-120691
Closed Access | Times Cited: 35
Mona F. El-Azab, Ahmed A. Al‐Karmalawy, Samar A. Antar, et al.
Life Sciences (2022) Vol. 303, pp. 120691-120691
Closed Access | Times Cited: 35
Design, synthesis, biological evaluation, and SAR studies of novel cyclopentaquinoline derivatives as DNA intercalators, topoisomerase II inhibitors, and apoptotic inducers
Mohamed M. Hammoud, Alaa S. Nageeb, M.A. Morsi, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 23, pp. 11422-11436
Closed Access | Times Cited: 34
Mohamed M. Hammoud, Alaa S. Nageeb, M.A. Morsi, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 23, pp. 11422-11436
Closed Access | Times Cited: 34
Ligand-based design, synthesis, computational insights, andin vitrostudies of novelN-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease
Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2112-2132
Open Access | Times Cited: 34
Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2112-2132
Open Access | Times Cited: 34
Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2
Samar A. Antar, Mohamed A. Saleh, Ahmed A. Al‐Karmalawy
Life Sciences (2022) Vol. 309, pp. 121048-121048
Open Access | Times Cited: 31
Samar A. Antar, Mohamed A. Saleh, Ahmed A. Al‐Karmalawy
Life Sciences (2022) Vol. 309, pp. 121048-121048
Open Access | Times Cited: 31
Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFR WT and EGFR T790M inhibitors
Tarfah Al‐Warhi, Ahmed A. Al‐Karmalawy, Ayman Abo Elmaaty, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 176-191
Open Access | Times Cited: 27
Tarfah Al‐Warhi, Ahmed A. Al‐Karmalawy, Ayman Abo Elmaaty, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 176-191
Open Access | Times Cited: 27
The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro , and in silico mechanistic investigations
Arafa Musa, Saleh Ihmaid, David L. Hughes, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 12411-12425
Open Access | Times Cited: 19
Arafa Musa, Saleh Ihmaid, David L. Hughes, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 12411-12425
Open Access | Times Cited: 19
New Dual Inhibitors of SARS-CoV-2 Based on Metal Complexes with Schiff-Base 4-Chloro-3-Methyl Phenyl Hydrazine: Synthesis, DFT, Antibacterial Properties and Molecular Docking Studies
Ahmed S. Al‐Janabi, Amin O. Elzupir, Mortaga M. Abou–Krisha, et al.
Inorganics (2023) Vol. 11, Iss. 2, pp. 63-63
Open Access | Times Cited: 19
Ahmed S. Al‐Janabi, Amin O. Elzupir, Mortaga M. Abou–Krisha, et al.
Inorganics (2023) Vol. 11, Iss. 2, pp. 63-63
Open Access | Times Cited: 19
Design and Synthesis of 2-(4-Bromophenyl)Quinoline-4-Carbohydrazide Derivatives via Molecular Hybridization as Novel Microbial DNA-Gyrase Inhibitors
Hany M. Abd El‐Lateef, Ayman Abo Elmaaty, Lina M. A. Abdel Ghany, et al.
ACS Omega (2023) Vol. 8, Iss. 20, pp. 17948-17965
Open Access | Times Cited: 19
Hany M. Abd El‐Lateef, Ayman Abo Elmaaty, Lina M. A. Abdel Ghany, et al.
ACS Omega (2023) Vol. 8, Iss. 20, pp. 17948-17965
Open Access | Times Cited: 19
Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro , molecular docking, molecular dynamics, and SAR studies
Faten Farouk, Ayman Abo Elmaaty, Ahmed Elkamhawy, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 18
Faten Farouk, Ayman Abo Elmaaty, Ahmed Elkamhawy, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 18
Cholinesterase Inhibitors from an Endophytic Fungus Aspergillus niveus Fv-er401: Metabolomics, Isolation and Molecular Docking
Ahmed A. Hamed, Riham A. El‐Shiekh, Osama G. Mohamed, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2559-2559
Open Access | Times Cited: 17
Ahmed A. Hamed, Riham A. El‐Shiekh, Osama G. Mohamed, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2559-2559
Open Access | Times Cited: 17
New 1,3,4-thiadiazoles as potential anticancer agents: pro-apoptotic, cell cycle arrest, molecular modelling, and ADMET profile
Mohamed H. Hekal, Paula S. Farag, Magdy M. Hemdan, et al.
RSC Advances (2023) Vol. 13, Iss. 23, pp. 15810-15825
Open Access | Times Cited: 16
Mohamed H. Hekal, Paula S. Farag, Magdy M. Hemdan, et al.
RSC Advances (2023) Vol. 13, Iss. 23, pp. 15810-15825
Open Access | Times Cited: 16